Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$0.49 - $0.96 $33,044 - $64,739
67,437 New
67,437 $62,000
Q4 2022

Feb 07, 2023

SELL
$2.03 - $4.28 $12,443 - $26,236
-6,130 Reduced 8.33%
67,437 $152,000
Q2 2022

Aug 05, 2022

SELL
$3.17 - $6.17 $567,436 - $1.1 Million
-179,002 Reduced 70.87%
73,567 $280,000
Q1 2022

May 06, 2022

BUY
$4.16 - $13.72 $3,993 - $13,171
960 Added 0.38%
252,569 $1.36 Million
Q4 2021

Feb 08, 2022

BUY
$10.83 - $18.41 $394,471 - $670,565
36,424 Added 16.93%
251,609 $3.4 Million
Q3 2021

Nov 08, 2021

SELL
$13.07 - $18.84 $127,314 - $183,520
-9,741 Reduced 4.33%
215,185 $3.87 Million
Q2 2021

Aug 10, 2021

BUY
$16.52 - $20.4 $21,773 - $26,887
1,318 Added 0.59%
224,926 $3.86 Million
Q1 2021

May 10, 2021

SELL
$16.56 - $25.46 $226,540 - $348,292
-13,680 Reduced 5.77%
223,608 $4.47 Million
Q3 2020

Nov 09, 2020

BUY
$16.59 - $24.79 $273,237 - $408,291
16,470 Added 7.46%
237,288 $3.94 Million
Q2 2020

Aug 07, 2020

BUY
$16.86 - $23.44 $11,633 - $16,173
690 Added 0.31%
220,818 $5.11 Million
Q1 2020

May 05, 2020

BUY
$14.47 - $27.96 $28,766 - $55,584
1,988 Added 0.91%
220,128 $3.93 Million
Q4 2019

Feb 03, 2020

SELL
$15.87 - $23.12 $37,643 - $54,840
-2,372 Reduced 1.08%
218,140 $4.71 Million
Q3 2019

Nov 07, 2019

BUY
$16.91 - $36.27 $2,705 - $5,803
160 Added 0.07%
220,512 $4.02 Million
Q2 2019

Aug 05, 2019

SELL
$31.0 - $36.3 $114,886 - $134,527
-3,706 Reduced 1.65%
220,352 $7.84 Million
Q1 2019

May 03, 2019

SELL
$31.58 - $46.35 $16,105 - $23,638
-510 Reduced 0.23%
224,058 $7.53 Million
Q4 2018

Feb 01, 2019

BUY
$30.43 - $56.65 $24,891 - $46,339
818 Added 0.37%
224,568 $7.38 Million
Q3 2018

Oct 31, 2018

BUY
$46.46 - $68.49 $151,506 - $223,345
3,261 Added 1.48%
223,750 $13.6 Million
Q2 2018

Aug 06, 2018

BUY
$46.25 - $104.45 $6.34 Million - $14.3 Million
137,184 Added 164.68%
220,489 $10.8 Million
Q1 2018

May 04, 2018

SELL
$57.4 - $108.44 $96,661 - $182,612
-1,684 Reduced 1.98%
83,305 $8.85 Million
Q4 2017

Feb 01, 2018

SELL
$23.02 - $60.5 $413,439 - $1.09 Million
-17,960 Reduced 17.45%
84,989 $5.08 Million
Q3 2017

Oct 31, 2017

BUY
$17.79 - $24.0 $1.83 Million - $2.47 Million
102,949
102,949 $2.47 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.